Abstract
Colorectal cancer (CRC) is one of the most common digestive cancers leading to deaths worldwide. In this study, we aimed to investigate the diagnostic value of miR-663 in CRC. The expression of miR-663 was detected by quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR). The association between miR-663 and clinical parameters of subjects was evaluated by chi-square test. Additionally, ROC (receiver operating characteristic) analysis was performed to evaluate the diagnostic role of miR-663 in CRC. The expression of miR-663 in CRC patients was significantly upregulated compared with benign colorectal disease patients and healthy controls (p
Author supplied keywords
Cite
CITATION STYLE
Wang, N., Zeng, L., Li, Z., Zhen, Y., & Chen, H. (2019). Serum miR-663 expression and the diagnostic value in colorectal cancer. Artificial Cells, Nanomedicine and Biotechnology, 47(1), 2650–2653. https://doi.org/10.1080/21691401.2019.1628036
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.